- Home
- RMTI vs QNCX Comparison
RMTI vs QNCX Comparison
Compare RMTI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- QNCX
- Stock Information
- Founded
- RMTI 1994
- QNCX 2012
- Country
- RMTI United States
- QNCX United States
- Employees
- RMTI N/A
- QNCX N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RMTI Health Care
- QNCX Health Care
- Exchange
- RMTI Nasdaq
- QNCX Nasdaq
- Market Cap
- RMTI 71.1M
- QNCX 62.0M
- IPO Year
- RMTI 1998
- QNCX 2019
- Fundamental
- Price
- RMTI $1.08
- QNCX $1.27
- Analyst Decision
- RMTI Strong Buy
- QNCX Strong Buy
- Analyst Count
- RMTI 2
- QNCX 5
- Target Price
- RMTI $4.00
- QNCX $8.00
- AVG Volume (30 Days)
- RMTI 322.3K
- QNCX 126.8K
- Earning Date
- RMTI 03-20-2025
- QNCX 05-12-2025
- Dividend Yield
- RMTI N/A
- QNCX N/A
- EPS Growth
- RMTI N/A
- QNCX N/A
- EPS
- RMTI N/A
- QNCX N/A
- Revenue
- RMTI $101,489,000.00
- QNCX N/A
- Revenue This Year
- RMTI N/A
- QNCX N/A
- Revenue Next Year
- RMTI $10.42
- QNCX N/A
- P/E Ratio
- RMTI N/A
- QNCX N/A
- Revenue Growth
- RMTI 21.38
- QNCX N/A
- 52 Week Low
- RMTI $1.07
- QNCX $0.51
- 52 Week High
- RMTI $5.15
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- RMTI 24.43
- QNCX 36.91
- Support Level
- RMTI $1.18
- QNCX $1.30
- Resistance Level
- RMTI $1.86
- QNCX $1.42
- Average True Range (ATR)
- RMTI 0.11
- QNCX 0.09
- MACD
- RMTI -0.04
- QNCX -0.00
- Stochastic Oscillator
- RMTI 1.89
- QNCX 4.17
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.